tumour antigen
An antigenic substance produced in tumour cells, which triggers an immune response in the host.
(via disialosyl Gb5(2-) )
|
|
α-NeuAc-(2→3)-β-D-Gal-(1→3)-[α-NeuAc-(2→6)]-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1ʼ)-Cer(d18:0)
|
SUBMITTER
|
Disialyl-Gb5Cer(d18:0)
|
SUBMITTER
|
DSGG(d18:0)
|
SUBMITTER
|
globoside DSGG (d18:0)
|
UniProt
|
N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]- N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1ʼ)-N-acylsphinganine
|
SUBMITTER
|
V3NeuAcIV6NeuAc-Gb5Cer(d18:0)
|
SUBMITTER
|